GAVI
Sign in to saveGAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private global health partnership with the goal of increasing access to immunization in poor countries. It is the largest organisation distributing donations of money towards vaccines; from 1990 to 2016, more than a third of donor money for immunisation was channelled through Gavi.
Key facts
- Organization.name
- Gavi (Global Alliance for Vaccines and Immunization)
- Organization.image
- File:2014_GAVI_logo.png
- Organization.caption
- 2014 logo, evoking UN logos
- Organization.type
- Public–private partnership
- Organization.location
- Geneva, Switzerland
- Organization.key_people
- Sania Nishtar, Seth Berkley, Dagfinn Høybråten, José Manuel Barroso, Anuradha Gupta
- Organization.status
- Active
- Organization.foci
- Vaccination
- Organization.leader_title
- CEO
- Organization.leader_name
- Sania Nishtar
via Wikipedia infobox
Article
13 sectionsContents
- Funding
- History and programs
- Vaccine development and advance market commitments
- Vaccination programs
- Pneumococcal vaccine
- Health systems strengthening debate
- Market shaping
- Pentavalent vaccine
- COVID-19 pandemic
- Awards
- See also
- References
- External links
GAVI, officially Gavi, the Vaccine Alliance (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) is a public–private global health partnership with the goal of increasing access to immunization in poor countries. It is the largest organisation distributing donations of money towards vaccines; from 1990 to 2016, more than a third of donor money for immunisation was channelled through Gavi.
Gavi supports the immunization of almost half the world's children. Gavi has helped immunize over 760 million children, preventing over 13 million deaths worldwide, helping increase diphtheria vaccine coverage in supported countries from 59% in 2000 to 81% in 2019, contributing to reducing child mortality by half. It also seeks to improve the economics of vaccines, negotiating bulk prices, supporting price discrimination, and reducing the commercial risks that manufacturers face when selling vaccines to the poor and developing vaccines. It also provides funding to strengthen health systems and train health workers across the developing world, though the effectiveness of its health-system-strengthening programs is disputed.